MY148277A - Treatment of cartilage disorders with fgf-18 - Google Patents

Treatment of cartilage disorders with fgf-18

Info

Publication number
MY148277A
MY148277A MYPI20090702A MYPI20090702A MY148277A MY 148277 A MY148277 A MY 148277A MY PI20090702 A MYPI20090702 A MY PI20090702A MY PI20090702 A MYPI20090702 A MY PI20090702A MY 148277 A MY148277 A MY 148277A
Authority
MY
Malaysia
Prior art keywords
treatment
fgf
osteoarthritis
cartilage disorders
cartilage disorder
Prior art date
Application number
MYPI20090702A
Other languages
English (en)
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of MY148277A publication Critical patent/MY148277A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI20090702A 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18 MY148277A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28

Publications (1)

Publication Number Publication Date
MY148277A true MY148277A (en) 2013-03-29

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20090702A MY148277A (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Country Status (11)

Country Link
CN (1) CN101505787B (sl)
BR (1) BRPI0715728A8 (sl)
DK (1) DK2054050T3 (sl)
ES (1) ES2392883T3 (sl)
MY (1) MY148277A (sl)
NZ (1) NZ574216A (sl)
PT (1) PT2054050E (sl)
RS (1) RS52710B (sl)
SI (1) SI2054050T1 (sl)
UA (1) UA99818C2 (sl)
ZA (1) ZA200900426B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2880179B1 (en) * 2012-08-06 2017-12-13 Merck Patent GmbH Genetic markers for predicting responsiveness to fgf-18 compound
AU2015220773B2 (en) * 2014-02-20 2020-10-08 Merck Patent Gmbh FGF-18 compound dosing regimen
PL3107592T3 (pl) * 2014-02-20 2019-02-28 Merck Patent Gmbh Implant zawierający FGF-18
MX2016010873A (es) * 2014-02-20 2016-11-17 Merck Patent Gmbh Factor de crecimiento de fibroblastos 18 en los procedimientos para el trasplante de injertos y para ingenieria de tejidos.
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
CN107849151B (zh) * 2015-07-15 2022-05-24 德益阳光生物技术（北京）有限责任公司 融合多肽及使用方法
US20180236032A1 (en) * 2015-08-13 2018-08-23 Merck Patent Gmbh Combination composition comprising fgf-18 compound
CA3162235A1 (en) * 2019-11-21 2021-05-27 Remedium Bio, Inc. Growth factor restoration
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (zh) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 用于治疗骨关节炎的mRNA及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003279835B2 (en) * 2002-10-07 2009-09-10 Zymogenetics, Inc. Methods of administering FGF18
EP2327413A1 (en) * 2004-07-06 2011-06-01 ZymoGenetics, Inc. Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
US7858341B2 (en) * 2004-12-10 2010-12-28 Zymogenetics, Inc. FGF18 production in prokaryotic hosts

Also Published As

Publication number Publication date
ES2392883T3 (es) 2012-12-14
NZ574216A (en) 2011-11-25
CN101505787B (zh) 2013-09-04
UA99818C2 (ru) 2012-10-10
CN101505787A (zh) 2009-08-12
BRPI0715728A2 (pt) 2013-09-17
ZA200900426B (en) 2010-04-28
SI2054050T1 (sl) 2012-12-31
RS52710B (en) 2013-08-30
PT2054050E (pt) 2012-09-17
DK2054050T3 (da) 2012-09-03
BRPI0715728A8 (pt) 2018-04-03

Similar Documents

Publication Publication Date Title
WO2008023063A3 (en) Treatment of cartilage disorders with fgf-18
MY148277A (en) Treatment of cartilage disorders with fgf-18
MY150702A (en) Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
TW200716672A (en) Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
MX337575B (es) Compuestos de sulfona y métodos para lafabricación y uso de éstos.
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
IL201479A (en) Use of tapentadol for the preparation of pain medication
MY162067A (en) Combination therapy for treatment of patients with neurological disorders and cerebral infarction
TW200734334A (en) Treatment of substance abuse
UA85471C2 (ru) Применение оксикодона для лечения висцеральной боли
NZ597419A (en) Formulations for the treatment of deep tissue pain
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
WO2007134326A3 (en) Methods for treating autoimmune diseases using a taci-ig fusion molecule
NZ591496A (en) A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
EA201070193A1 (ru) Лечение детских опухолей
IL198202A0 (en) Peptide-cytotoxic conjugates
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
MX2008013477A (es) Compuestos biciclicos de tetrahidropirrol.
IL197769A (en) The history of morphine, medicinal preparations containing them and their use in the preparation of pain medication
WO2010072774A3 (de) 5-ht2a und 5-ht2b rezeptorantagonisten zur behandlung der spinalkanalstenose
MX2009011214A (es) Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales.